CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use ...
Nalu Medical CEO and president Tom West commented: “This FDA clearance strengthens our mission to make peripheral nerve stimulation therapy appropriate for a broader patient population.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback